NLM Logo

GHRH(1-29)NH2, PhAcTyr(1)-Arg(2)-P(H)e(4-CL)(6)-Ala(8)-Tyr(Me)(10)-His(11)-Abu(15)-His(20)-Nle(27)-Arg(28)-HLCr(29)- MeSH Supplementary Concept Data 2024


MeSH Supplementary
GHRH(1-29)NH2, PhAcTyr(1)-Arg(2)-P(H)e(4-CL)(6)-Ala(8)-Tyr(Me)(10)-His(11)-Abu(15)-His(20)-Nle(27)-Arg(28)-HLCr(29)-
Unique ID
C534070
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C534070
Entry Term(s)
1-PhAcTyr-2,28-Arg-6-P(H)e(4-CL)-8-Ala-9-Har-10-Tyr(Me)-11,20-His-15-Abu-27-Nle-29-HLCr-GHRH(1-29)nh2
GHRH(1-29)NH2, phenylacetyltyrosyl(1)-arginyl(2)-P(H)e(4-CL)-alanyl(8)-homoarginyl(9)-O-methyltyrosyl(10)-histidyl(11)-alpha-aminobutyryl(15)-histidyl(20)-norleucyl(27)-arginyl(28)-HLCr(29)-
JMR 132
JMR-132
JMR132
Registry Number
0
Heading Mapped to
Sermorelin / *analogs & derivatives
Frequency
20
Note
an antineoplastic agent
Source
Oncol Rep 2008 Nov;20(5):1289-94
Date of Entry
2008/12/29
GHRH(1-29)NH2, PhAcTyr(1)-Arg(2)-P(H)e(4-CL)(6)-Ala(8)-Tyr(Me)(10)-His(11)-Abu(15)-His(20)-Nle(27)-Arg(28)-HLCr(29)- Preferred
JMR 132 Narrower
page delivered in 0.005s